Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(100.0%)
1Total
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05364814Completed

Use of Probiotic Yogurt in Obese Women

Role: collaborator

NCT04812574Phase 3Completed

Hypertonic Saline Injection For Urinary Incontinence

Role: lead

NCT01931891Unknown

Extracellular Matrix Remodeling of the Umbilical Cord and Placenta in Preeclampsia

Role: collaborator

All 3 trials loaded